"10.1371_journal.pone.0070878","plos one","2013-09-27T00:00:00Z","Mariana Brait; Leonel Maldonado; Maartje Noordhuis; Shahnaz Begum; Myriam Loyo; Maria Luana Poeta; Alvaro Barbosa; Vito M Fazio; Roberto Angioli; Carla Rabitti; Luigi Marchionni; Pauline de Graeff; Ate G J. van der Zee; G Bea A Wisman; David Sidransky; Mohammad O Hoque","Department of Otolaryngology â€ Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America; Clinical Research Coordination, Instituto Nacional de CÃ¢ncer (INCA)-Brazilian National Cancer Institute, Rio de Janeiro, Brazil; Department of Gynecologic Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, Maryland, United States of America; Department of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari, Bari, Italy; Department of Pathology, Hospital San Jose Tec de Monterrey, Monterrey, Nuevo Leon, Mexico; Laboratory for Molecular Medicine and Biotechnology Center for Integrated Research, University Campus Bio-Medico of Rome, Rome, Italy; Department of Gynecology, University Campus Bio-Medico of Rome, Rome, Italy; Department of Pathology, University Campus Bio-Medico of Rome, Rome, Italy; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America; Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America","Conceived and designed the experiments: MOH, DS, MB, L. Maldonado. Performed the experiments: MB, L. Maldonado, MN, SB, ML, PG. Analyzed the data: MN, L. Marchionni, GBAW, MB, L. Maldonado, MOH, SB. Contributed reagents/materials/analysis tools: GBAW, MN, MLP, SB, AB, VMF, RA, CR, AGJZ. Wrote the paper: MB, L. Maldonado, MOH.","We have the following interests. Under a licensing agreement between Oncomethylome Sciences, SA (now MDxHealth) and the Johns Hopkins University, D.S. is entitled to a share of royalty received by the University upon sales of diagnostic products described in this article. D.S. owns Oncomethylome Sciences, SA stock, (now MDxHealth) which is subject to certain restrictions under University policy. D.S. is a paid consultant to Oncomethylome Sciences, SA (now MDxHealth) and is a paid member of the companys Scientific Advisory Board. A. van der Zee was a paid consultant to MDxHealth (Previously Oncomethylome Sciences SA). Author MOH is a PLOS ONE Editorial Board member. There is a patent application that includes some of the data to be published here in this article: WO201/099489, EP2401408A2 â€ Ovarian Cancer Methylome. There are no further patents, products in development or marketed products to declare. This does not alter our adherence to all the PLOS ONE policies on sharing data and materials.","2013","09","Mariana Brait","MB",16,TRUE,4,2,2,2,FALSE,FALSE,TRUE,11,"1;3;4;7;8;9;10;12;14;15;16",TRUE
